Editorial
World J Virol
10(2):30-33.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.30
Abstract (1129)
|
Core Tip (1161)
|
Full Article (HTML) (2449)
|
Figures (1-4) (1226)
|
Full Article (PDF)-1129K (445)
|
Audio-540K (15)
|
Peer-Review Report-149K (206)
|
Answering Reviewers-64K (191)
|
Received: 01/14/2021
|
Revised: 01/30/2021
|
Accepted: 02/05/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12020)
|
Similar Articles (1)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
World J Virol
10(2):34-52.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.34
Abstract (1832)
|
Core Tip (1273)
|
Full Article (HTML) (14822)
|
Tables (1-3) (647)
|
Full Article (PDF)-950K (1141)
|
Audio-1256K (35)
|
Peer-Review Report-242K (345)
|
Answering Reviewers-119K (362)
|
Received: 12/29/2020
|
Revised: 01/23/2021
|
Accepted: 03/12/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (17)
|
Total Visits (27269)
|
Similar Articles (734)
|
Timeline of Article Publication (1)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review
World J Virol
10(2):53-61.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.53
Abstract (1108)
|
Core Tip (1162)
|
Full Article (HTML) (3248)
|
Tables (1-3) (666)
|
Full Article (PDF)-837K (343)
|
Audio-1070K (36)
|
Peer-Review Report-217K (219)
|
Answering Reviewers-69K (214)
|
Received: 12/12/2020
|
Revised: 01/28/2021
|
Accepted: 03/08/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (12104)
|
Similar Articles (720)
|
Timeline of Article Publication (9)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Trends in the management of infectious disease under SARS-CoV-2 era: From pathophysiological comparison of COVID-19 and influenza
World J Virol
10(2):62-68.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.62
Abstract (1204)
|
Core Tip (1179)
|
Full Article (HTML) (3481)
|
Figures (1-2) (735)
|
Tables (1-3) (633)
|
Full Article (PDF)-4630K (429)
|
Audio-444K (17)
|
Peer-Review Report-202K (232)
|
Answering Reviewers-117K (255)
|
Received: 12/18/2020
|
Revised: 01/16/2021
|
Accepted: 02/20/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (13821)
|
Similar Articles (828)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Epidemiological characterization and geographic distribution of human immunodeficiency virus/acquired immunodeficiency syndrome infection in North African countries
World J Virol
10(2):69-85.
Published online Mar 25, 2021.
doi: 10.5501/wjv.v10.i2.69
Abstract (1251)
|
Core Tip (1121)
|
Article Highlights (1233)
|
Full Article (HTML) (4267)
|
Figures (1-8) (700)
|
Tables (1-1) (674)
|
Full Article (PDF)-10779K (426)
|
Audio-581K (29)
|
Peer-Review Report-162K (269)
|
Answering Reviewers-206K (287)
|
Received: 11/04/2020
|
Revised: 12/22/2020
|
Accepted: 01/08/2021
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (16419)
|
Similar Articles (1)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
